NTNCB hydrochloride

CAS No. 191931-56-3

NTNCB hydrochloride( —— )

Catalog No. M27672 CAS No. 191931-56-3

NTNCB hydrochloride is an antagonist of neuropeptide Y (NPY) Y5 receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 204 Get Quote
10MG 293 Get Quote
25MG 493 Get Quote
50MG 709 Get Quote
100MG 972 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NTNCB hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    NTNCB hydrochloride is an antagonist of neuropeptide Y (NPY) Y5 receptor.
  • Description
    NTNCB hydrochloride is an antagonist of neuropeptide Y (NPY) Y5 receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    utrophin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    191931-56-3
  • Formula Weight
    508.07
  • Molecular Formula
    C25H34ClN3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (246.03 mM)
  • SMILES
    Cl.[O-][N+](=O)c1ccccc1S(=O)(=O)NC[C@@H]1CC[C@H](CNC[C@H]2CCc3ccccc3C2)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.De Moor O, et al. Discovery and SAR of 2-arylbenzotriazoles and 2-arylindazoles as potential treatments for Duchenne muscular dystrophy. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4828-31.
molnova catalog
related products
  • Histrelin acetate

    Histrelin acetate is a nonapeptide analog of gonadotropin-releasing hormone (GnRH) with added potency. It acts on particular cells of the pituitary gland called gonadotropes when present in the bloodstream. Histrelin stimulates these cells to release luteinizing hormone and follicle-stimulating hormone. Thus it is considered a gonadotropin-releasing hormone agonist or GnRH agonist.

  • S107

    S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

  • Secoisolariciresinol...

    Secoisolariciresinol Diglucoside was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage.